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Abstract
Background: Limited research exists on researchers’ knowledge transfer and exchange (KTE) in the eastern
Mediterranean region (EMR). This multi-country study explores researchers’ views and experiences regarding the
role of health systems and policy research evidence in health policymaking in the EMR, including the factors that
influence health policymaking, barriers and facilitators to the use of evidence, and the factors that increase
researchers’ engagement in KTE.
Methods: Researchers who published health systems and policy relevant research in 12 countries in the EMR
(Bahrain, Egypt, Iran, Jordan, Lebanon, Libya, Morocco, Oman, Palestine, Sudan, Syria, and Yemen) were surveyed.
Descriptive analysis and Linear Mixed Regression Models were performed for quantitative sections and the simple
thematic analysis approach was used for open-ended questions.
Results: A total of 238 researchers were asked to complete the survey (response rate 56%). Researchers indicated
transferring results to other researchers (67.2%) and policymakers in the government (40.5%). Less than one-quarter
stated that they produced policy briefs (14.5%), disseminated messages that specified possible actions (24.4%),
interacted with policymakers and stakeholders in priority-setting (16%), and involved them in their research (19.8%).
Insufficient policy dialogue opportunities and collaboration between researchers and policymakers and stakeholders
(67.9%), practical constraints to implementation (66%), non-receptive policy environment (61.3%), and politically
sensitive findings (57.7%) hindered the use of evidence. Factors that increase researchers’ engagement in KTE
activities in the region were associated with involving policymakers and stakeholders at various stages such as
priority-setting exercises and provision of technical assistance.
Conclusions: Researchers in the EMR recognize the importance of using health systems evidence in health
policymaking. Potential strategies to improve the use of research evidence emphasize two-way communication
between researchers and policymakers. Findings are critical for the upcoming World Health Report 2012, which will
emphasize the significance of conducting and translating health research to inform health policies.
Introduction
The role of research in improving health systems and
healthcare delivery is becoming increasingly recognized
by policymakers and researchers worldwide. Despite glo-
bal calls for promoting research and its application
[1-3], the gap between health systems research evidence
and the use of evidence in policymaking and practice
c o n t i n u e st oe x i s t .E x a m i n i n ge f f o r t st ob r i d g et h i sg a p
and monitoring changes in the nature and extent of
researchers’ engagement in bridging efforts provides a
valuable tool for those calling for and funding these
efforts and those designing and implementing effective
bridging strategies [4]. Knowledge transfer and exchange
(KTE), which is an interactive process involving the
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researcher producers, emerged as a result of growing
evidence that the successful uptake of knowledge
requires more than one-way communication but rather
genuine interaction among researchers, decision makers,
and other stakeholders [5].
In the Eastern Mediterranean Region (EMR), the role
of research in policymaking has been repeatedly empha-
sized [6-8]. In its recent strategic directions for research
for health, WHO Eastern Mediterranean Regional Office
(WHO EMRO) emphasized the forceful implementation
and expansion of research for health as a fundamental
tool for health development and informing health policy
changes [1]. Health research systems in the EMR are
not yet well developed to generate and use knowledge
to improve health, reduce inequality, and contribute to
economic development [9]. The region also suffers from
the paucity in health systems research and systematic
reviews [10,11]. It has a lower average number (213) of
research for health publications compared to the global
average (551) [12]. Moreover, a recent print media ana-
lysis in 44 low- to middle-income countries (LMICs),
which included several countries from the EMR, showed
that the region is among the lowest in terms of the arti-
cles that describe or use health systems research [13].
Furthermore, the number of researchers in research and
development who are trained to work in any field of
science from the EMR is relatively low (ranging from 29
to 1,927 per million people) compared to the United
States (4,484 per million) [14]. Even in parts of the
region where there is significant human capital to con-
duct research for health, the production, dissemination,
and utilization of evidence remains weak mainly due to
insufficient demand for research [15], El-Jardali et al.,
unpublished manuscript]. In a recent priority-setting
exercise conducted with policymakers, stakeholders, and
researchers from the region, participants called for
further exploration of health systems research into pol-
icy, engaging policymakers in health systems research,
and conducting surveys to better understand the policy-
making context and design effective KTE strategies for
the region [10].
Limited research exists on researchers’ KTE activities
in the EMR [16-20]. We are not aware of a survey that
has been conducted about the KTE activities of
researchers in the region. The objective of this study is
to explore how researchers view and experience the role
of health systems research in health policymaking in the
EMR, including the factors that influence health policy-
making and the factors that increase researchers’
engagement in KTE activities. This paper also details
the barriers and facilitators to the use of evidence in the
policymaking process.
Methods
A cross-sectional survey of researchers who published
health systems and policy-relevant research in 12 coun-
tries in the EMR was conducted. The survey was devel-
oped based on several sources [4,21,22]. The main
themes and most of the questions were adapted from
the questionnaire by Lavis et al. [4]. Additional ques-
tions were adapted from the questionnaires by Campbell
et al. [21] and Tehran University of Medical Sciences
[22]. The wording of questions was retained whenever
possible; however, some questions were customized to
f i tt h ec o n t e x to ft h er e g i o n .O p e n - e n d e dq u e s t i o n s
were also added to the quest i o n n a i r e .T h es u r v e yw a s
translated to Arabic by a professional translator and
back-translated to English with minimal differences. The
survey was piloted with a health systems and policy
researcher from the region and was further modified.
Institutional review board (IRB) approval was obtained
prior to data collection from the American University of
Beirut (AUB).
The survey consisted of a demographics section, four
main quantitative scales, and seven open-ended ques-
tions. In the quantitative section, the first scale consisted
of 25 items that assessed researchers’ activities with
regards to KTE including their KTE audience, research
products, dissemination, and contact and exchange with
policymakers and stakeholders. In addition, six yes/no
items requested participants to indicate whether they
have the skills and necessary KTE training and have
undertaken KTE activities (Tables 1 and 2). The second
scale consisted of 13 items that assessed the invest-
ments/resources available to researchers to support their
KTE activities (Table 3). The third scale consisted of 11
items that explored researchers’ views on policymakers’
usage of evidence in addition to the factors the influence
the use of evidence in policymaking (Table 3). The
fourth and final scale consisted of researchers’ views on
the health policymaking context in the region (Tables
3). Additionally, a series of yes/no items asked partici-
pants to indicate their needs to ensure that research is
transferred to health policymakers and stakeholders
(Table 4).
For the open-ended questions, respondents were asked
to list their recent KTE activities and another question
asked them to list the knowledge transfer strategy that
had the greatest impact on influencing decisions. In the
third question, respondents were asked to list examples
on: where evidence was available but was not used; the
formulation of a policy where evidence was available
and used; and where evidence was not available but was
needed. In addition, three open-ended questions asked
respondents to list at least three major barriers and
facilitators of the use of evidence in policymaking in
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tions to improve the use of evidence in policymaking.
Open-ended items also asked participants to indicate
whether their engagement with policymakers and stake-
holders compromised their intellectual and academic
independence and to indicate whether they have under-
taken KTE activities, as well as to list three top factors
that exerted the strongest influence in the policymaking
process in their respective countries.
Sampling
There is no inventory of health systems and policy
researchers in the EMR. As such, purposive sampling
was conducted to identify researchers who published
health systems and policy-relevant research from the
region or conducting research in the region. Corre-
sponding authors who had published relevant articles
between the years 2000 and 2008 in local or interna-
tional journals indexed on Medline or EMBASE were
sampled. This was done through a search strategy for
health systems and policy research that has been devel-
oped to optimize sensitivity and specificity [23]. The
EMR countries included in the search strategy were:
Bahrain, Egypt, Iran, Jordan Lebanon, Libya, Morocco,
Oman, Palestine, Sudan, Syria, and Yemen. Countries
were selected based on their interest and participation
in the launch meeting of the Evidence Informed Policy
Network East Mediterranean Region (EVIPNet EMR)
that took place in January 2009. EVIPNet EMR is a
social network that encourages the use of evidence in
the policymaking process. It includes researchers, policy-
makers, and civil society members from the EMR.
After identification of corresponding authors, informa-
tion along with their emails was extracted. A thorough
internet search was conducted to obtain for authors if
they were not available in the publication.
Authors of these articles were not limited to study
countries. The sampling frame therefore included
authors who had at least one health systems and policy
Table 1 Demographic information of respondents
N%
Gender
Male 81 62%
Female 49 38%
Country where researchers are currently working
Lebanon 19 13%
Palestine 19 13%
USA 14 10%
Jordan 13 9%
Oman 10 7%
Syria 9 6%
Morocco 7 5%
Yemen 6 4%
Egypt 5 4%
Bahrain 5 4%
UK 5 4%
Sudan 4 3%
Saudi Arabia 3 2%
Canada 3 2%
Iran 3 2%
Kuwait 2 1%
Iraq 2 1%
Germany 2 1%
Italy 2 1%
Libya 1 1%
Mali 1 1%
Switzerland 1 1%
Qatar 1 1%
Nigeria 1 1%
France 1 1%
Ireland 1 1%
Sweden 1 1%
Denmark 1 1%
Age
Mean (Standard Deviation) 48.77 (9.87)
Degrees (the 133 respondents were
allowed to choose multiple degrees)
PhD 91 68%
MD 79 59%
MS 55 41%
BS 50 38%
MPH 23 17%
MBA 16 12%
Diploma 10 8%
MA 8 6%
BA 7 5%
BSN 7 5%
Other 3 2%
Midwife 2 2%
MSN 2 2%
PharmD 1 1%
Table 1 Demographic information of respondents
(Continued)
Main research domains
Other public health related research 100 57%
Health Systems and Policy 75 43%
Type of institution where respondents work
Academic University 112 84%
Teaching hospital setting 46 35%
Government department or agency 25 19%
Regional health authority or equivalent 13 10%
Research Institute (not within a University) 12 9%
Non-teaching hospital setting 7 5%
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published in a local or international journal.
To supplement our list of sampled authors, an
optional question was added at the end of the survey
asking respondents to indicate whether they think we
should contact specific researchers who may be inter-
ested in completing the survey. This technique helped
increase our sample size and identify 16 more
researchers from the region who may not have been
identified otherwise.
In total, 282 researchers were identified through this
sampling process. Upon sending invitations to complete
the survey, 44 emails were identified as inactive or
incorrect. As such, a total of 238 researchers received
the invitation to complete the survey, 133 responded
giving a response rate of approximately 56%.
Table 2 KTE activities that researchers frequently or always undertook in their research domains
Total
N (%)
95% Confidence
Interval
Transferring research frequently or always to the following categories of potential users
Other researchers or academic institutions (e.g., conferences, forums). 88 (67%) 57.77% to 73.76%
Policy makers in the government (e.g., Ministry of Health, Ministry of Social Affairs, Ministry of Education,...). 53 (41%) 31.93% to 48.34%
Service providers (e.g., clinicians, nurses, pharmacists,...). 44 (34%) 25.66% to 41.46%
Directors in healthcare institutions (e.g., hospitals, Primary Healthcare Centers). 36 (28%) 20.24% to 35.18%
Directors in donor agencies (e.g., United States Agency for International Development (USAID), United Nations,
World Bank, World Health Organization (WHO),...).
35 (27%) 19.57% to 34.39%
General public or service recipients (e.g., citizens, patients, clients). 27 (21%) 14.34% to 27.93%
Directors of Non-Governmental Organizations (NGOs). 25 (19%) 13.07% to 26.28%
Directors in a health professional association or group (e.g., Syndicate of Hospitals, Order of Physicians, Order
of Nurses).
22 (17%) 11.18% to 23.78%
Knowledge transfer and exchange activities conducted frequently or always in relation to the
production and dissemination of evidence
Produce articles and reports of high priority to health policy and systems. 54 (41%) 32.63% to 49.10%
Translate high priority policy concerns into priority research themes and/or questions. 48 (37%) 28.42% to 44.54%
Disseminate articles and reports to health policy makers and stakeholders. 35 (27%) 19.57% to 34.39%
Disseminate messages that specified possible actions to health policy makers and stakeholders. 32 (24%) 17.59% to 31.99%
Provide health policy makers and stakeholders with research results through the web (emails, newsletters,
listserves)
26 (20%) 13.70% to 27.10%
Produce policy briefs to inform discussions of high priority policy issues 19 (15%) 9.34% to 21.24%
Contacting and exchanging research frequently or always with health policy makers and stakeholders
Involved policy makers and stakeholders but had difficulty contacting them. 38 (29%) 21.58% to 36.77%
Provided technical assistance to policy makers and stakeholders through short-term work through expert
advisory committees, conferences, or forums.
38 (29%) 21.58% to 36.77%
Interacted with health policy makers and stakeholders through informal conversations with personal contacts. 36 (28%) 20.24% to 35.18%
Participated in meetings for presentation of results from HPSR and/or your own research to health policy
makers and stakeholders.
35 (27%) 19.57% to 34.39%
Actively participated in health policy development committees or technical committees that help in decision
making.
34 (26%) 18.91% to 33.59%
Provided technical assistance through long-term formal collaborations between your institution and policy
makers and stakeholders for sustained technical capacity development.
30 (23%) 16.28% to 30.37%
Involved policy makers and stakeholders in your research (in the development of joint proposals/research
methodology and tools/analysis & write-up/publications).
26 (20%) 13.70% to 27.10%
Interacted with health policy makers and stakeholders as part of a priority-setting process to identify high-
priority health policy issues and research themes.
21 (16%) 10.57% to 22.93%
Trained health policy makers and stakeholders to acquire, assess, interpret, and apply health research findings. 21 (16%) 10.57% to 22.93%
Interacted with credible messengers/sources (i.e., people who are not researchers but are seen by policy
makers and stakeholders as credible sources of research) to promote use of evidence from HPSR and/or your
own research
20 (15%) 9.95% to 22.09%
Developed relationships with print, radio and/or television journalists to promote use of evidence from HPSR
and/or your own research.
17 (13%) 8.14% to 19.52%
HPSR: health policy and systems research
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The survey was administered online using the software
LimeSurvey 1.90. LimeSurvey does not require respon-
dents to provide their names or any personal informa-
tion. It randomly generates and assigns respondents
with a unique token, which cannot be matched with
participants’ responses and is only used to avoid dupli-
cate responses. Respondents were approached by an
email, in both English and Arabic, with the link to the
online survey. They were informed that they could com-
plete the survey in either English or Arabic. The survey
link allowed respondents to choose their language pre-
ference using a drop-down list. Non-respondents were
sent automated reminders two weeks after the first con-
tact and four weeks after the first reminder. It is worth
noting that only three respondents completed the survey
in Arabic.
Data analysis
Responses were exported from LimeSurvey to the Statis-
tical Package for Social Sciences (SPSS) 19.0 for analysis.
All analyses were carried out at a significance level of
0.05. Descriptive analysis was performed. For items
assessing researchers’ views and attitudes, a five-point
scale of strongly agree, agree, neither agree or disagree,
disagree, and strongly disagree was used. Whereas, for
items assessing the frequency with which researchers
undertook KTE activities, the scale ranged from never,
rarely, occasionally, frequently, to always.
For closed-ended questions, the uppermost and lower-
most ends of the scale were combined i.e., strongly agree
with agree and strongly disagree with disagree; never with
rarely and frequently with always. Descriptive analysis was
performed for closed-ended questions. Confidence Inter-
vals (95%) were constructed for scale-based questions.
Linear Regression Models were used to examine
whether transferring research results or undertaking KT
activities was affected by selected independent variables.
Three dependant variables were constructed using
exploratory factor analysis; two related to the transfer of
research results and the third related to undertaking KT
activities (henceforth referred to as production and dis-
semination of evidence). The questions relating to trans-
fer of research to potential users (eight items) loaded on
three factors; the first related to transfer of results to
policymakers, directors of NGOs, and donor agencies;
the second related to transfer of results to directors of
health institutions, professional associations, and service
providers. Eigen values and % variance explained were
acceptable and, as such, two scores were computed
relating to these two factors by summation of the score
of items. This resulted in two dependant variables, the
first related to policymakers (those associated with gov-
ernment, NGOs, and donor agencies) and the second
related to provider organizations (those associated with
syndicates, orders, healthcare institutions, and service
providers).
The third factor related to production and dissemina-
tion of evidence from the samples’ own research (six
items). Exploratory factor analysis showed loading on
one factor and acceptable eigen values and % variance
explained. Similarly to the first two factors, a score was
created for this factor by summation of the scores of
items.
The independent variables included in this model
related to undertaking KTE activities related to contact
and exchange with health policymakers and stakeholders
in addition to the investments/resources available for
the production and transfer and exchange of evidence
from health policy and systems research (HPSR). Multi-
collinearity between independent variables was tested
for prior to data analysis using the Pearson correlation
coefficient statistic, and no multicollinearity was
detected.
Open-ended questions were analyzed using the simple
thematic analysis approach. Responses were broken into
Table 3 Skills and training to undertake KTE activities
Total
N (%)
Answered ‘Yes’ to the following questions regarding their skills and training for KTE activities
Undertook any knowledge transfer and exchange activities 77 (58%)
Feel that they have sufficient skills and training to produce Systematic reviews 73 (66%)
Produced Newspaper articles 65 (59%)
Produced Systematic Reviews (e.g., reviews of the research literature that follows explicit rules to reduce bias in searching the
literature, identifying eligible articles, extracting data, etc.)
53 (48%)
Feel that they have sufficient skills and training to produce Policy briefs 50 (46%)
Produced Policy briefs 45 (41%)
Had training on how to communicate research evidence to policymakers and stakeholders 25 (23%)
Consider that their engagement/exchange with policymakers and stakeholders compromises their intellectual and academic
independence
19 (14%)
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available for KTE, factors that influence the use of evidence in health policymaking and that influence health
policymaking
Total
N (%)
95% Confidence
Interval
Agreed or Strongly Agreed with the following statements concerning the support for knowledge
transfer and exchange in country/region
Policymakers and stakeholders have access to HPSR through a network of researchers or academic institutions. 60 (46%) 36.91% to 53.59%
Policymakers and stakeholders have access to HPSR through a searchable database with an Internet
connection within their organization.
59 (45%) 336.19% to 52.84%
Policymakers and stakeholders show little regard for the value of evidence. 56 (43%) 34.05% to 50.60%
Policymakers and stakeholders have the expertise for acquiring, assessing quality and local applicability of
HPSR, and applying it in health policymaking.
40 (31%) 22.93% to 38.34%
Policymakers and stakeholders systematically access HPSR (i.e., regularly search databases for HPSR) in your
country.
27 (21%) 14.34% to 27.93%
Agreed or Strongly Agreed with the following statements on use of evidence from HPSR by health
policymakers and stakeholders in your country/region
Lack of coordination between policymakers and researchers hindered the use of evidence from HPSR in the
health policymaking process.
85 (65%) 55.46% to 71.58%
Policymakers and stakeholders consider that the available evidence has little practical policy applications. 52 (40%) 31.22% to 47.59%
Evidence from HPSR was not presented to policymakers and stakeholders in a timely manner and in a format
that they can understand.
48 (37%) 28.42% to 44.54%
Policymakers and stakeholders do not use scientific evidence in the policymaking process whenever it is
available and supplied to them.
37 (28%) 20.91% to 35.98%
Evidence from HPSR did not help health policymakers and stakeholders to identify and/or choose policy
alternatives.
30 (23%) 16.28% to 30.37%
Evidence from HPSR did not help raise health policymakers and stakeholders’ awareness on policy issues. 30 (23%) 16.28% to 30.37%
Policymakers and stakeholders consider that the available evidence lacks credibility. 19 (15%) 9.34% to 21.24%
Agreed or Strongly Agreed with the following statements on investments and resources available for
the production and transfer and exchange of evidence from HPSR
Funding sources (e.g., granting agencies) encourage knowledge transfer and exchange activities. 73 (65%) 46.41% to 63.09%
International funding is available for undertaking HPSR. 55 (50%) 33.34% to 49.85%
Funders formulate their priorities and calls for proposals in response to national and regional needs. 52 (47%) 31.22% to 47.59%
Regional funding is available for undertaking HPSR. 42 (38%) 24.29% to 39.90%
National funding is available for undertaking HPSR. 38 (34%) 21.58% to 36.77%
Incentives for knowledge transfer and exchange are available (e.g., performance incentives for knowledge
transfer and exchange and proper criteria of promotion) within your organization
26 (23%) 13.70% to 27.10%
Policymakers and stakeholders clearly articulate priorities for health systems and policy research. 23 (21%) 11.81% to 24.61%
Policymakers and stakeholders provide adequate funding for priority research. 22 (20%) 11.18% to 23.78%
Agreed or Strongly Agreed with the following factors that influence the use of evidence in health
policymaking in the region
Use of evidence from HPSR in policy was hindered by insufficient policy dialogue opportunities, networking,
and collaboration between researchers and policymakers and stakeholders.
72 (68%) 45.67% to 62.37%
Use of evidence from HPSR in policy was hindered by practical constraints to implementation such as financial
implications.
70 (66%) 44.19% to 60.92%
Use of evidence from HPSR in policy was hindered by a non-receptive policy environment. 65 (61%) 40.53% to 57.28%
Use of evidence from HPSR in policy was hindered by findings that were politically sensitive or were
inconsistent with a policy direction.
61 (58%) 37.63% to 54.33%
Agreed or Strongly Agreed with the following factors that influence health policymaking in the region
Lack of coordination in governmental/ministerial relations across different ministries (such as the Ministry of
Health, Ministry of Finance, etc.) hindered the health policymaking process.
82 (82%) 53.17% to 69.48%
Policy formulation is usually based on internal Ministry of Health discussions, donor preferences, and ad hoc
process rather than evidence based processes.
76 (76%) 48.65% to 65.24%
There is insufficient information about how health policies are being made. 74 (73%) 47.16% to 63.81%
Lack of coordination in government/health provider relations hindered the health policymaking process. 70 (70%) 44.19% to 60.92%
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followed which involved organizing concepts into
themes [24]. These data were then analyzed by recurring
themes and emerging patterns. Analysis was conducted
by two members of the research team with a high level
of agreement between the two. Disagreements were dis-
cussed until consensus was reached.
Results
Quantitative section
Descriptive analysis
Male researchers comprised 62% of the sampled
researchers. A total of 80% of the 133 respondents
reported working in a country from the region, while
the remaining 20% reported working outside the region.
A total of 18% of researchers reported that their main
research domain is health systems and policy research,
while 57% reported that their main research domain is
other public health-related domains including epide-
miology, communicable diseases, maternal and child
health, and 25% worked in both research domains
(Table 1). Most researchers are currently working in an
academic university (85%), 37% are working in a teach-
ing hospital setting, and 17% in a government depart-
ment (Table 1). Researchers indicated always or
frequently transferring results to other researchers
(67%), policymakers in the government (40%), and ser-
vice providers (34%) (Table 1).
None of the KTE activities related to the production
and dissemination of research and contact and exchange
with policymakers and stakeholders were undertaken by
more than one-half of the researchers (Table 2). Less
than one-quarter of respondents stated that they
produced policy briefs (15%), disseminated messages
that specified possible actions (24%), provided research
results through the web (20%), provided technical assis-
tance through long-term formal collaborations with pol-
icymakers and stakeholders (23%), interacted with
policymakers and stakeholders as part of a priority-set-
ting process (16%), and involved policymakers and sta-
keholders in their research (20%) (Table 2). Although
most researchers stated that they have sufficient skills
and training to produce systematic reviews (66%), less
than one-half have ever conducted or produced sys-
tematic reviews (48%) (Table 3).
More than one-half of researchers reported that lack
of coordination between policymakers and researchers
hindered the use of evidence in policymaking (65%)
(Table 4). While most researchers indicated that funding
sources encourage KTE activities (65%), less than one-
quarter reported that policymakers and stakeholders
provide adequate funding for priority research (20%)
and clearly articulate priorities for health systems and
policy research (21%) (Table 4).
Only some researchers stated that policymakers sys-
tematically access HPSR (21%), although around more
than one-third of researchers stated that policymakers
and stakeholders have access to HPSR through a search-
able database with an internet connection (45%) or
through a network of researchers or academic institu-
tions (46%). Some also stated that they have the exper-
tise for acquiring, assessing the quality and local
applicability of HPSR, and applying it in health policy-
making (31%). Researchers also indicated that policy-
makers and stakeholders show little regard for the value
of evidence (43%) (Table 4).
Table 4 Support available for KTE, practices of health policymakers and stakeholders, investments and resources
available for KTE, factors that influence the use of evidence in health policymaking and that influence health policy-
making (Continued)
Limited health funding exerted a strong influence on the health policymaking process. 62 (62%) 38.35% to 55.07%
Donor organizations (e.g., United States Agency for International Development (USAID), United Nations, World
Bank, World Health Organization (WHO)) exerted a strong influence on the health policymaking process.
59 (59%) 36.19% to 52.84%
Values of governing parties exerted a strong influence on the health policymaking process. 50 (50%) 29.82% to 46.07%
Media exerted a strong influence on the health policymaking process. 47 (47%) 27.73% to 43.77%
Other countries’ health policies exerted a strong influence on the health policymaking process. 43 (43%) 24.97% to 40.68%
Physician associations exerted a strong influence on the health policymaking process. 37 (37%) 20.91% to 35.98%
Public opinion exerted a strong influence on the health policymaking process. 32 (32%) 17.59% to 31.99%
Private health providers exerted a strong influence on the health policymaking process. 29 (29%) 15.63% to 29.56%
Private insurers exerted a strong influence on the health policymaking process. 27 (27%) 14.34% to 27.93%
Research about problems related to healthcare or health systems exerted a strong influence on the health
policymaking process.
25 (25%) 13.07% to 26.28%
Other types of health professional associations exerted a strong influence on the health policymaking process
(e.g., Syndicate of hospitals).
22 (22%) 11.18% to 23.78%
Nursing associations exerted a strong influence on the health policymaking process. 6 (6%) 2.08% to 9.49%
HPSR: health policy and systems research
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making was hindered by insufficient policy dialogue
opportunities, networking, and collaboration between
researchers and policymakers and stakeholders (68%),
practical constraints to implementation (66%), a non-
receptive policy environment (61%), and findings that
were politically sensitive (58%) (Table 4). In terms of
researchers’ views on the health policymaking process,
they stated that there is insufficient information about
how health policies are being made (73%) and that pol-
icy formulation is based on internal Ministry of Health
discussions, donor preferences, and ad hoc process
rather than evidence-based processes (76%). The major-
ity stated that lack of coordination in relations across
different ministries (82%) and between the government
and health providers (70%) hindered the health policy-
making process. Furthermore, limited health funding
(62%), donor organizations (59%), values of governing
parties were reported to exert a strong influence on the
health policymaking process (50%) (Table 4). Research-
ers’ responses to an open-ended question confirmed
that values of governing political parties and political
interests of policymakers, health funding and resources,
and donor organizations and international organizations
(e.g., WHO) are the top factors that influenced health
policymaking processes in the region.
Some researchers stated that incentives for KTE activ-
ities were available (23%) (Table 4). Furthermore, the
majority indicated that they need web support (78%),
KTE support units or institutional mechanisms in aca-
demic institutions (68%), and funding for KTE as part of
the research process (62%) (Table 5).
Linear regression models
Results of the two linear regression models revealed sev-
eral factors associated with the degree of researchers’
engagement in transferring research and production and
dissemination of research.
Researchers’ engagement in transferring research to
policymakers and providers organizations
Results showed that sampled researchers increased
transfer of research results to policymakers by 0.229 (p
= 0.026) for each unit increase on the item describing
developing relationships with print, radio, and/or televi-
sion journalists to promote use of evidence (Table 6).
An increase of 0.346 (p = 0.001) was observed in trans-
fer of research to policymakers for a one-unit increase
in availability of international funding for undertaking
HPSR (Table 6).
An increase of 0.301 (p = 0.002) in transfer of
research to provider organizations was observed for a
one-unit increase in trying to involve policymakers and
stakeholders but facing difficulty. However, a decrease
of 0.402 (p = 0.008) in transfer of research to provider
organizations was observed for every unit increase in
providing technical assistance through long-term formal
collaborations with policymakers and stakeholders for
sustained technical capacity development (Table 6).
Finally, an increase of 0.203 (p = 0.028) in transfer of
results to provider organizations was observed for every
unit increase in having funding sources which encourage
transfer and exchange activities (Table 6).
It was interesting to observe similar degrees of increase
in transfer of research results to policymakers (beta =
0.314, p = 0.004) and provider organizations (beta =
0.314, p = 0.010) for every unit increase in involving pol-
icymakers and stakeholders in research (Table 6).
Researchers’ engagement in the production and
dissemination of evidence
Results of the linear regression model revealed that a
one-unit increase in interacting with health policy-
makers and stakeholders as part of a priority-setting
process to identify high-priority health policy issues and
research themes, increased production and dissemina-
tion of evidence by 0.364 (p = 0.001). In addition, an
increase of 0.190 (p = 0.023) was observed in production
and dissemination of evidence for every unit increase in
training health policymakers and stakeholders to
acquire, assess, interpret, and apply health research.
(Table 7).
Responses to Open-Ended Questions
Researchers’ recent KTE activities and most effective
strategies
More than one-half of researchers (58%) stated that they
have undertaken KTE activities (Table 2). When asked
to list their recent KTE activities, most researchers sta-
ted that they have conducted research relevant to prior-
ity policy issues. The majority reported that they have
discussed their findings with their target audience in
workshops and presented findings in conferences as well
as in publications. Some researchers also stated that
they have conducted capacity-building sessions for pol-
icymakers and stakeholders on research methods and
interpretation of findings. Only a few researchers parti-
cipated in joint research studies with policymakers,
wrote newspaper articles and policy briefs, and dissemi-
nated findings to their target audience using the web
and newsletters.
Most researchers stated that personal contacts with
policymakers and direct face-to-face meetings are the
knowledge transfer strategies with the greatest impact
on influencing policymakers. One researcher explained
that ‘the main strategy is though personal contacts. If
you know someone in charge, you can communicate the
findings and help them develop the appropriate policy
in line with evidence. If the person in charge is powerful
enough policies and decisions are then influenced.’ The
media, including newspaper articles, was also mentioned
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strategy. Some researchers also stated that presentations,
conferences, and workshops, as well as enhanced fund-
ing for knowledge transfer activities can have a strong
impact on influencing policymakers.
Examples on the formulation of a health policy where
evidence was available but not used, available and used, or
needed but not available
The most frequently cited examples by researchers on
policies where evidence was used, where evidence was
available but was not used, and where evidence was
needed but was not available are presented in Table 8.
Formulation of a health policy where evidence was
available but not used
Most responses (21%) indicated that evidence from
research on healthcare quality as well as evidence on
best practices was not used for formulating policies
related to healthcare quality. As one researcher from
Lebanon stated ‘data from indicators on the quality of
maternal healthcare could have better informed hospital
accreditation processes.’ Responses (16%) also indicated
that evidence was not used to formulate policies on
health financing arrangements especially related to
national health insurance policies. A researcher from
Jordan stated that ‘[evidence] on an integrated national
health insurance system was introduced to the ministry
of health in Jordan [but was not taken into] considera-
tion, despite its serious findings.’ Several responses from
Lebanon and Syria stated that although evidence was
available, it was not used to formulate tobacco control
policies (Table 8).
Formulation of a health policy where evidence was
available and used
Most responses (28%) indicated that establishing screen-
ing programs for chronic diseases was based on evi-
dence from the prevalence and cost-effectiveness of
these programs. For example, a researcher from Oman
stated that evidence on the ‘high number of congenitally
deaf children [led] to the [establishment] of a newborn
hearing screening program.’ Responses (18%) also
indicated that evidence from research was used to estab-
lish prevention programs for infectious diseases.
Furthermore, several responses demonstrated that evi-
dence was used to formulate nutrition policies such as
for ionization of salt, vitamin fortification, and food-
handling guidelines (Table 8).
Formulation of a health policy where evidence was needed
but not available
The majority of responses (18%) indicated that local
research evidence on age maternal mortality and mor-
bidity was needed to inform policies on reproductive
and maternal health. Responses also indicated that evi-
dence was needed on implementing healthcare quality
procedures and measuring performance as well as on
the transmission and prevalence of human immunodefi-
ciency virus (Table 8).
Barriers and facilitators to the use of evidence in
policymaking of health policymaking and strategies to
improve evidence to policy
The majority of responses cited lack of funding (20%),
overriding political forces (13%), lack of political will
and corruption (10%), and lack of communication and
insufficient dialogue with policymakers (9%), as well as
lack of appropriately trained policymakers in using evi-
dence (9%) as barriers to the use of research in health
policymaking (Table 9).
Most responses indicated that communication and
networking with policymakers (18%) and the availability
of funding (18%) and health research on policy priorities
(12%), political pressure to use research in policymaking
in certain fields (8%), and the wide dissemination of
research (6%) are facilitators to KTE activities. Several
responses also indicated that policymakers’ belief in the
importance of evidence-informed policymaking and
public opinion and stakeholders pressures to use evi-
dence in policymaking also facilitate the use of research
in health policymaking (Table 9).
The majority of responses suggested establishing easy
methods for communication, networking, and dialogue
with policymakers (20%), increasing funding and
Table 5 Researchers’ needs to ensure that evidence from research is transferred to health policy makers and
stakeholders
Total
N (%)
Answered ‘Yes’ to the following statements regarding their needs to support KTE activities
Knowledge transfer and exchange support units/institutional mechanisms in academic institutions 91 (68%)
Funding for knowledge transfer and exchange as part of the research process 83 (62%)
Training on communicating evidence from research to policymakers and stakeholders 78 (59%)
Knowledge brokers (i.e., people who bring researchers and their target audiences together and build relationships among them to
make knowledge transfer and exchange more effective)
60 (45%)
Web support 50 (78%)
Other 11 (8%)
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city of policymakers in locating evidence, assessing its
quality, cost effectiveness, and local applicability (8%), in
addition to training researchers on conducting health
systems and policy research and KTE strategies (6%),
and improving the dissemination of research (6%).
Responses also suggested conducting sensitization and
awareness workshops on evidence informed
Table 6 Linear Regression Model for transfer of research to policymakers and service providers*
Transferring research
to policymakers
Transferring research
to providers
organizations
Beta†
(Standard
Error)
P-
Value
Beta
(Standard
Error)
P-
Value
Constant 0.368 (0.493) 0.457 0.364 (0.493) 0.505
Frequency of undertaking each of these knowledge transfer and exchange activities
related to contact and exchange with health policymakers and stakeholders
1- Interacted with credible messengers/sources (i.e., people who are not researchers but are
seen by policymakers and stakeholders as credible sources of research) to promote use of
evidence from HPSR and/or your own research
-0.022 (0.081) 0.817 0.127 (0.089) 0.229
2- Developed relationships with print, radio and/or television journalists to promote use of
evidence from HPSR and/or your own research.
0.229 (0.091) 0.026 -0.168 (0.101) 0.142
3- Participated in meetings for presentation of results from HPSR and/or your own research to
health policymakers and stakeholders.
-0.027 (0.091) 0.805 0.008 (0.100) 0.946
4- Tried to involve policymakers and stakeholders but had difficulty contacting them. -0.033 (0.068) 0.699 0.301 (0.075) 0.002
5- Provided technical assistance to policymakers and stakeholders through short-term work
through expert advisory committees, conferences, or forums.
0.03 (0.106) 0.819 -0.402 (0.116) 0.008
6- Provided technical assistance through long-term formal collaborations between your
institution and policymakers and stakeholders for sustained technical capacity development.
0.012 (0.111) 0.931 0.296 (0.122) 0.056
7- Interacted with health policymakers and stakeholders through informal conversations with
personal contacts.
0.056 (0.091) 0.584 -0.007 (0.100) 0.948
8- Interacted with health policymakers and stakeholders as part of a priority-setting process to
identify high-priority health policy issues and research themes.
0.196 (0.118) 0.144 0.114 (0.13) 0.446
9- Involved policymakers and stakeholders in your research (in the development of joint
proposals/research methodology and tools/analysis & write-up/publications).
0.314 (0.091) 0.004 0.314 (0.100) 0.01
10- Actively participated in health policy development committees or technical committees
that help in decisionmaking.
0.079 (0.084) 0.447 0.103 (0.092) 0.38
11- Trained health policymakers and stakeholders to acquire, assess, interpret, and apply
health research findings.
0.025 (0.081) 0.799 0.106 (0.089) 0.345
Investments/resources available to you for the production and transfer and exchange of
evidence from HPSR
1. National funding is available for undertaking HPSR. -0.062 (0.091) 0.554 0.178 (0.100) 0.133
2- Regional funding is available for undertaking HPSR. -0.066 (0.103) 0.539 0.00 (0.113) 0.998
3- International funding is available for undertaking HPSR. 0.346 (0.105) 0.001 -0.131 (0.116) 0.239
4- Funding sources (e.g., granting agencies) encourage knowledge transfer and exchange
activities.
0.021 (0.084) 0.801 0.203 (0.093) 0.028
5- Funders formulate their priorities and calls for proposals in response to national and
regional needs.
0.011 (0.089) 0.91 -0.003 (0.098) 0.977
6- Policymakers and stakeholders provide adequate funding for priority research. 0.068 (0.093) 0.487 0.037 (0.102) 0.739
7- Policymakers and stakeholders clearly articulate priorities for health systems and policy
research.
-0.198 (0.108) 0.078 0.03 (0.119) 0.81
8- Incentives for knowledge transfer and exchange are available (e.g., performance incentives
for knowledge transfer and exchange and proper criteria of promotion) within your
organization.
-0.036 (0.077) 0.655 -0.028 (0.085) 0.755
Adjusted R
2 0.465 0.331
F 6.030 3.8585
P-value < 0.001 < 0.001
N 110 110
† Beta stands for the average change in the score of the dependant variables per unit increase in independent variable scores.
* Results in bold are statistically significant at 0.05 level
HPSR: health policy and systems research
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Page 10 of 16Table 7 Linear Regression Model for production and dissemination of evidence*
Production and
dissemination of
evidence
Beta (Standard
Error)
P-
Value
Constant 0.786 (0.348) 0.026
Frequency of undertaking each of these knowledge transfer and exchange activities related to contact and
exchange with health policymakers and stakeholders
1- Interacted with credible messengers/sources (i.e., people who are not researchers but are seen by policymakers
and stakeholders as credible sources of research) to promote use of evidence from HPSR and/or your own research
0.017 (0.057) 0.825
2- Developed relationships with print, radio and/or television journalists to promote use of evidence from HPSR and/
or your own research.
0.071 (0.065) 0.398
3- Participated in meetings for presentation of results from HPSR and/or your own research to health policymakers
and stakeholders.
0.172 (0.064) 0.058
4- Tried to involve policymakers and stakeholders but had difficulty contacting them. 0.087 (0.048) 0.211
5- Provided technical assistance to policymakers and stakeholders through short-term work through expert advisory
committees, conferences, or forums.
0.033 (0.075) 0.766
6- Provided technical assistance through long- term formal collaborations between your institution and policymakers
and stakeholders for sustained technical capacity development.
-0.025 (0.078) 0.824
7- Interacted with health policymakers and stakeholders through informal conversations with personal contacts. 0.053 (0.064) 0.526
8- Interacted with health policymakers and stakeholders as part of a priority-setting process to identify high-priority
health policy issues and research themes.
0.364 (0.084) 0.001
9- Involved policymakers and stakeholders in your research (in the development of joint proposals/research
methodology and tools/analysis & write-up/publications).
0.019 (0.064) 0.833
10- Actively participated in health policy development committees or technical committees that help in
decisionmaking.
0.121 (0.059) 0.161
11- Trained health policymakers and stakeholders to acquire, assess, interpret, and apply health research findings. 0.19 (0.057) 0.023
Investments/resources available to you for the production and transfer and exchange of evidence from HPSR
1. National funding is available for undertaking HPSR. 0.125 (0.064) 0.154
2- Regional funding is available for undertaking HPSR. -0.12 (0.073) 0.181
3- International funding is available for undertaking HPSR. 0.105 (0.074) 0.202
4- Funding sources (e.g., granting agencies) encourage knowledge transfer and exchange activities. -0.08 (0.06) 0.234
5- Funders formulate their priorities and calls for proposals in response to national and regional needs. 0.072 (0.063) 0.359
6- Policymakers and stakeholders provide adequate funding for priority research. -0.049 (0.065) 0.55
7- Policymakers and stakeholders clearly articulate priorities for health systems and policy research. -0.009 (0.076) 0.92
8- Incentives for knowledge transfer and exchange are available (e.g., performance incentives for knowledge transfer
and exchange and proper criteria of promotion) within your organization.
-0.064 (0.054) 0.342
Adjusted R
2 0.634
F 11.040
P-value < 0.001
N 110
† Beta stands for the average change in the score of the dependant variables per unit increase in independent variable scores.
* Results in bold are statistically significant at 0.05 level
HPSR: health policy and systems research
Table 8 Most frequently mentioned examples on the formulation of a health policy where evidence was available but
not used, available and used, or needed but not available
Formulation of a health policy where
evidence was available but not used
(n = 43)
Formulation of a health policy where
evidence was available and used (n = 39)
Formulation of a health policy where evidence was
needed but was not available (n = 40)
￿ Evidence- based practice and
healthcare quality
9(21%) ￿ Establishing screening programs
for chronic diseases
11(28%) ￿ Reproductive health and maternal health 7(18%)
￿ Health financing especially
national health insurance
7(16%) ￿ Establishing prevention
programs for infectious diseases
7(18%) ￿ Implementing healthcare quality
procedures and measuring performance
5(13%)
￿ Tobacco control 4(9%) ￿ Nutrition 4(10%) ￿ HIV Transmission and prevalence 4(10%)
n = total number of responses to each question
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tions for policymakers to usee v i d e n c ei np o l i c y m a k i n g
(Table 9).
Attitudes of researchers on KTE activities and academic
independence
Only 14.4% of researchers stated that their engagement
and exchange with policymakers and stakeholders com-
promises their intellectual and academic independence
(Table 2). They explained that engaging with policy-
makers may result in policymakers’ misinterpretations of
sensitive findings to better suit their political agendas,
which compromises the integrity of their work and their
intellectual independence. As one researcher stated,
‘there is sometimes an unwelcome pressure to ‘spin’ the
findings to fit the view of the policymakers.’
Discussion
Study findings indicate that sampled researchers’
engagement in a variety of KTE activities, including the
production and dissemination of research as well as
contact and exchange with policymakers and stake-
holders, was undertaken by less than one-half of
researchers in the EMR. The low level of engagement in
KTE activities of the sampled researchers may be attrib-
uted to the little support available in their environment
for engaging in KTE activities, including the lack of
incentives in the form of performance incentives and
proper criteria of promotion within their organizations
for undertaking KTE activities. Factors that increase
engagement in KTE activities were mainly associated
with involving policymakers and stakeholders at various
stages, such as in priority-setting exercises and in the
provision of technical assistance. Results from regression
analysis, particularly transfer of results to provider orga-
nizations, may indicate that researchers focus on this
group when they have difficulty contacting policymakers
or do not have the opportunity to provide technical
assistance to them. It is worth noting that the findings
of the factor analysis pertaining to this specific scale
(transfer of research results) can also indicate the need
to differentiate between groups of policymakers and sta-
keholders in future research, because researchers
appeared to interact with them in different ways.
Furthermore, results from open-ended questions indi-
cate that the utilization of evidence in policymaking var-
i e sd e p e n d i n go nt h et y p eo fe v i d e n c ea v a i l a b l e .F o r
example, certain types of research can often be over-
looked in the region due to contextual factors and con-
straints that are more relevant for the decision-making
process, such as financial implications, lack of trust in
the value of local research, and political influences.
Low level of researchers’ engagement in KTE activities
was also reported from a survey of researchers from
LMICs and from Iran [4,17,25]. Researchers’ perceived
barriers to the use of research in policymaking, and
their views on the factors that compete with research in
the health policymaking process are also aligned with
t h o s ep r e v i o u s l yr e p o r t e df r o mt h er e g i o n[ 1 , 1 6 , 2 0 ]a n d
further corroborate those reported from studies in
LMICs [26,27]. The existence of structures and pro-
cesses to link researchers and their target audience as
well as the stability in researchers’ contracts and having
managers and public (government) policymakers among
their target audiences were also found to predict
researchers’ engagement in bridging activities in LMICs
[4]. As in many LMICs, the local research capacity in
Table 9 Most frequently mentioned barriers and facilitators to the use of evidence in policymaking and strategies to
improve evidence to policy
Barriers to evidence-informed policies
(n = 150)
Facilitators to evidence-informed policies
(n = 83)
Strategies to improve evidence to policy (n = 119)
￿ Lack of funding for health
research
30(20%) ￿ Communication and networking 15(18%) ￿ Communication, networking, and dialogue 24(20%)
￿ Over-riding political forces 19(13%) ￿ Availability of funding for health
research
15(18%) ￿ Increase funding and investments in health
research
16(13%)
￿ Lack of political will and
corruption
15(10%) ￿ Availability of health research on
policy priorities
10(12%) ￿ Build capacity of policymakers 9(8%)
￿ Lack of communication and
insufficient dialogue
14(9%) ￿ Political pressure to use research
in policymaking in certain fields
7(8%) ￿ Train researchers on conducting health
systems and policy research and KTE
strategies
7(6%)
￿ Lack of appropriately trained
policymakers in use of evidence
13(9%) ￿ Wide dissemination of research 5(6%) ￿ Improve dissemination of research 7(6%)
￿ Belief in the importance of
evidence-informed policymaking
4(5%) ￿ Conduct sensitization and awareness
workshops on evidence informed
policymaking
6(5%)
￿ Public opinion and stakeholders
pressures
4(5%) ￿ Provide incentives or legislations for
policymakers to use evidence in
policymaking
6(5%)
n = total number of responses to each question, respondents listed up to three responses.
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research, is still lacking [28]. Due to the scarcity of
research capacity to undertake health systems and
implementation research in the region, it is highly
recommended that efforts be directed towards improv-
ing the design, robustness, and applicability of the evi-
dence generated in one setting to allow its utilization in
other settings [28].
Our study has three main strengths: it is among the
very few studies (if not the first) to explore the views
and practice of researchers on their KTE activities and
the use of health systems evidence in the EMR; it com-
bined different types of research methods and survey
q u e s t i o n s ;a n di tp r o v i d e dd a t ao nt h ef a c t o r st h a tp r e -
dict researchers’ engagement in KTE activities in the
region. However, limitations related to challenges in
identifying researchers in the region should be acknowl-
edged. Specifically, only 282 researchers were identified
given that we limited the search to health systems and
policy research articles published between 2000 and
2008; therefore, researchers who published before or
after this period were not contacted and included in our
sampling frame. Because there is no inventory of public
health systems researchers in the region, we only
focused on researchers with published literature. Several
researchers who develop reports and commissioned
papers that do not get published may have been missed
b e c a u s ew ed i dn o ti d e n t i f ya uthors of grey literature.
Despite these challenges, responses from researchers
provide some insight about the policymaking process in
general and use of evidence in policymaking in the
region. Social desirability bias inherent with self-
reported questionnaires is another limitation of this
study. For example, the number of respondents who
indicated producing systematic reviews is surprisingly
high given the low number of systematic reviews from
the region [10]. Respondents may have provided the
answers they considered desirable by the investigators.
Responses may present either true beliefs or perceptions
of what respondents thought researchers wanted to
hear, or a combination of both. However, it can be
safely assumed that the results are not overly inflated
because of the positive nature of most of the questions.
Furthermore, self-reports of current behavior provide
clear information on where improvements should be
implemented [29].
Study implications and potential strategies for increasing
the use of health systems evidence into health
policymaking in the EMR
Knowledge translation (KT) was emphasized in WHO
EMRO’s recent strategic direction for research for health
[1]. WHO EMRO strategic actions to ensure that quality
evidence is translated into policy include access to
unpublished scientific literature in the region, publishing
of results in an understandable and accessible way, pro-
moting importance of research and knowledge sharing,
and strengthening EVIPNet in the region. Based on
study findings, potential strategies for increasing the use
of health systems evidence into health policies in the
EMR were identified, which further advocate those
established by WHO EMRO.
Increasing interaction and communication between
researchers and policymakers was identified as key to
improving the use of evidence in policymaking. This
implication is further supported by a recent study con-
ducted in Iran, which emphasized the need for a proper
and logical connection between the production of scien-
tific evidence, policymaking, and implementation [20].
Literature shows that communication and exchange
between policymakers and stakeholders, especially in the
form of interpersonal relationships, increases the pro-
spects for research use [5,30,31]. Building partnerships
between researchers and research users as well as invol-
ving policymakers in all stages of the research process,
including conceptualization, design, and dissemination,
offer a great potential for overcoming mistrust between
researchers and policymakers and for increasing
research use [32,33]. A greater opportunity for interac-
tion with policymakers has become available to
researchers in the region through social networks, such
as the WHO sponsored EVIPNet EMR. It is important
to further expand on these networks to strengthen com-
munication and exchange in the region as well as to
empower rights to access knowledge and innovation [1].
Our findings show that there is a need for increased
funding in KTE activities and in priority health research
in the region. In fact, funding for scientific research in
the majority of countries in the region is among the
lowest in the world [34] and has been identified among
the priorities for research centers from the region [21].
Funding bodies can also play a major role in enhancing
research use by requiring that a detailed KTE compo-
nent be present as part of the research process. This
strategy has been previously shown to increase the
uptake of research [5,32]. Funders should also allocate
resources to primary research dedicated to the evalua-
tion of innovative KTE strategies [5]. They should also
require grant proposals to build on systematic reviews
of existing evidence in order to avoid duplication and
reinventing the wheel and to encourage the production
of research that can better inform health priorities [35].
For example, the National Institute for Health Research
(NIHR) Health Technology Assessment Programme rou-
tinely requires or commissions systematic reviews before
funding primary studies, publishes all research as web-
accessible monographs, and has made all new protocols
freely available [35].
El-Jardali et al. Implementation Science 2012, 7:2
http://www.implementationscience.com/content/7/1/2
Page 13 of 16However, it is important to note that funding by itself,
even if provided by governments, is not enough to
ensure effective involvement of the research community
in policy development. It should be accompanied by
strengthening the capacity of both policymakers and
researchers to demand and provide evidence [36,37].
While literature emphasizes the importance of training
policymakers in fostering a more positive attitude
towards the use of research findings and boosting its
receptivity [37,38], no established training and education
programs that target policymakers and stakeholders in
the EMR are available to date. Incentives in the form of
legislations can also be established to encourage or even
oblige policymakers to use evidence in policymaking, as
also suggested in other countries from the region [20].
Support units to assist researchers in their KTE activ-
ities can provide capacity-building and information tech-
nology support for researchers including decision
support tools, databases, and web technology [16]. The
active engagement with policymakers and stakeholders
requires that researchers acquire a set of novel skills.
First, as our study revealed, it is often hard for some
researchers in the region to balance the competing
agendas of policymakers with their own research and
their local organizations. Close integration may under-
mine the independence of research [21,32]. Therefore,
training should be provided to researchers on choosing
whether and how to involve decision makers, who to
involve, as well as on determining the goals for their
involvement [32,33].
Researchers should also be trained on increasing the
relevance of their research including focusing on priority
policy issues, providing actionable messages and infor-
mation on the quality and local applicability of their
research. Literature shows that clear summaries of find-
ings with recommendations for action, good quality
research, and research that include effectiveness data
facilitate the use of research in policymaking [5,31].
Furthermore, ‘one-stop shops’ for relevant, high-quality
and optimally packaged systematic reviews and related
products have recently gained more recognition for link-
ing evidence to policymaking and are viewed as key ele-
ments for strategies to strengthen national health
systems [39,40]. Health Systems Evidence (HSE) was
developed as a one-stop shop for policy- and manage-
ment-related systematic reviews and related products,
and is the only resource that answers questions about
how to organise health systems in order to ensure that
cost-effective programmes and services are provided to
those who need them [39]. The Cochrane Library is a
one-stop shop for clinical programmes and services or
medicines, and ‘health-evidence.ca’ was developed for
public health programmes and services [41]. To enhance
their KTE skills, researchers should also be trained on
developing policy briefs and conducting policy dialogues
using the SUPPORT tools (SUPporting POlicy relevant
Reviews and Trials) as guides [42,43]. Researchers
should also focus their efforts on the production of sys-
tematic reviews of the literature that could better inform
the local health context [30]. For example, a study from
the region suggested several interventions for promoting
systematic reviews, including training of researchers on
systematic reviews, mandatory education as part of the
curricula for research degrees, the publication of specia-
lized journals, as well as improving the quality of local
primary research [18]. In addition, more training to
researchers should be provided on using the media,
including newspapers, websites, television, and radio, for
presenting and discussing their research results and
implications. Recent findings show that when research-
ers receive basic training for increasing their communi-
cation and KTE skills, better results regarding research
transfer and utilization can be achieved [17,44].
It is also necessary that policies and procedures of
academic institutions in the EMR reflect that KTE is a
priority. Efforts should be directed towards revising pro-
motion and employment criteria so as to include
researchers’ KTE activities and research utilization. A
strategy that can be employed by academic institutions
to motivate researchers to engage in KTE is to develop
a measure of the impact of research on policy. This
would enable the inclusion of KTE in promotion and
funding criteria and would incentivize researchers for
engaging in KTE activities [22,44,45].
Literature shows that the success of KTE strategies
highly depends on tailoring the approach to the barriers
and facilitators found within a particular and unique set-
ting [46-48]. In order to design effective KTE strategies,
an increased understanding of the barriers and facilita-
tors for the use of evidence is required from researchers.
The current survey provides researchers and those inter-
ested in the design and implementation of KTE strate-
gies with an overview of the barriers and facilitators
found in the region as well as the contextual factors
that compete with evidence in the policymaking envir-
onment, which can inform them in tailoring their KTE
approach to the local setting.
The evidence base to support the effectiveness of KTE
strategies is not definitive and is relatively scarce in
developing countries generally [5], and in the EMR spe-
cifically. Currently, there is not enough evidence on
which KTE strategy works best and in what context and
where the responsibility for KTE rests [5]. Furthermore,
limited evidence exists, especially in the EMR, on the
effectiveness of utilizing knowledge brokers, intermedi-
aries that enhance communication and exchange
between researchers and policymakers. Therefore, addi-
tional research is needed to examine the effectiveness of
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is also needed to develop and test conceptual KTE mod-
els and frameworks that guide those undertaking KTE
activities in tailoring their approach to the regional set-
ting. Similar studies in the region should be repeated in
a few years to measure changes in researchers’ KTE
activities and environment. Given that many organiza-
tions and funders, such as EVIPNet EMR, are currently
mobilizing resources and efforts to support KTE plat-
forms in the region, it will be interesting to examine the
outcome of these organizational activities on research-
ers’ KTE activities.
Conclusion
Health researchers in several countries from the EMR
recognize the importance of using health systems evidence
in health policymaking. However, more efforts are needed
from the side of both researchers and policymakers as well
as academic institutions to enhance the use of evidence in
health policymaking in the region. This study provides
baseline data on the practices and views of researchers in
the region. Findings from this study may help guide strate-
gies for enhancing the use of health systems evidence in
policymaking with emphasis on the two-way communica-
tion and partnerships between researchers and policy-
makers. Study findings are critical in light of the
upcoming World Health Report 2012, which will empha-
size the significance of conducting and translating health
research to help inform health policies.
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